STEMCELL Technologies Canada Inc.: federal grants and contributions: 6 agreements; $81.7M value; 3 departments; 6 programs.
Assay record ASY-CA-1CAOSYF0B2 · Cite as: Assay Systems, “STEMCELL Technologies Canada Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/stemcell-technologies-canada-inc/
These two biomanufacturing Good Manufacturing Practices (GMP) facilities will be established to enable the production of essential Messenger Ribonucleic Acid (mRNA) vaccines, viral diagnostics and antibody therapeutic inputs at a large scale of up to 5000 litres per batch.
The project involves designing, building and operating a multiproduct Advanced Biologics Manufacturing Facility capable of manufacturing products such as cell culture media, cell separation products and ancillary reagents.
Improve quality management system & upgrade cell separation products for new markets
STEMCELL Technologies will manufacture a proprietary medium developed for mammalian cell culture and protein expression used in the vaccine manufacturing process.
To develop tools and assays for 3D cell culture
To accelerate the screening and validation of therapeutic drugs to treat COVID-19, Project Exhale will develop two critical new media products and associated protocols to culture human alveolar cells in 2D and 3D.
All grants from Innovation, Science and Economic Development Canada
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.